Reinforcing the fight against Ebola in Guinea
As reinforcement to help fight Ebola in the affected West African countries, the European Centre for Disease Prevention and Control is deploying four teams of French-speaking epidemiologists to support surveillance and response in Guinea.
As reinforcement to help fight Ebola in the affected West African countries, the European Centre for Disease Prevention and Control is deploying four teams of French-speaking epidemiologists to support surveillance and response in Guinea. This is done in coordination and close partnership with the Commission and the World Health Organization. Their work will cover four prefectures in Guinea and will support the local government health authorities for the surveillance and response activities at community level, filling this critically important current gap in the most affected areas of Guinea.
As a scientific and technical agency, ECDC has initially focused on providing evidence and guidance to the European Commission and EU Member States in order to best prepare and respond to any imported Ebola case. This has been done by issuing frequently updated rapid risk assessments, surveillance updates, information to travelers as well as various technical guidance documents. ECDC will continue to provide these updates and deliver technical and scientific support.
Thanks to sustained and co-ordinated action amongst the European Commission, EU Member States, and partners Europe is now increasingly well prepared to handle any imported Ebola case. In the affected countries, contributions made by the global community have helped to avoid the worst case scenarios discussed early in the epidemic. Protecting Europe and the world, however, requires a multidimensional approach and the threat of Ebola can only be eliminated by supporting those affected by it in West Africa.
Ebola treatment trial: two drugs identified as more effective
14 Aug 2019 - Two out of the four drugs tested in a multi-drug randomised control trial have been found more effective in treating Ebola, the World Health Organization announced on Monday. The Data and Safety Monitoring Board, an independent body that has been reviewing interim safety and efficacy data, has therefore recommended that the study be stopped and that all future patients be randomized to receive either REGN-EB3 or mAb114, in what is being considered an extension phase of the study.
Ebola outbreak in the Democratic Republic of the Congo: ECDC updates assessment for Europe
19 Jul 2019 - After the Ebola virus disease outbreak was declared a Public Health Emergency of International Concern on 17 July 2019, ECDC updated its risk assessment for the EU/EEA on the on-going outbreak: the overall risk of introduction and further spread of the Ebola virus within the EU/EEA remains very low.
Epidemiological update: Ebola virus disease outbreak in North Kivu and Ituri Provinces, Democratic Republic of the Congo
25 Jan 2019 - Since the beginning of the outbreak and as of 23 January 2019, according to the Ministry of Health of the Democratic Republic of the Congo, there have been 715 Ebola virus disease cases (666 confirmed, 49 probable), including 443 deaths (394 in confirmed and 49 in probable cases).